A Phase 2b study of M1Pram in patients with type 1 diabetes and a BMI>30kg/m²

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 24 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Sep 2024 According to an Adocia media release, preparation for the Phase 2b clinical program in the United States, which plans to include 140 patients with type 1 diabetes and a BMI greater than 30 kg/m, is ongoing, and clinical batches have been manufactured.
19 Sep 2024 Status changed from planning to recruiting, according to an Adocia media release.
06 Mar 2024 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com